Antisense oligonucleotide PB2 AUG
Alternative Names: S-ODN-PB2-AUGLatest Information Update: 22 Aug 2002
At a glance
- Originator Nonindustrial source
- Class Antisense oligonucleotides; Antivirals
- Mechanism of Action Antisense RNA modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 06 Nov 1998 Preclinical development for Influenza virus infections in Japan (Unknown route)